Turn genomic complexity into clinical clarity









Evidence
Validated on clinically realistic rare disease cases
SeqSMART was evaluated in a retrospective benchmarking study using real clinical rare disease cases, including singleton, duo, and trio configurations
Benchmark study
SeqSMART was evaluated on a retrospective rare disease cohort with real diagnostic complexity, including mixed family structures, inheritance models, multi-variant cases, and previously unresolved cases.
Stats
256
Pedigrees evaluated
Real-world rare disease cohort
314
Individuals analyzed
Clinical diagnostic setting
98.5%
Top-10 recall
Clinically reported variants recovered within top-ranked candidates
34
Additional solved cases
Cases unresolved in the original workflow
Singleton benchmark: cumulative recall
SeqSMART vs Exomiser

98.5% vs 74.6%
Top-10 recall
SeqSMART showed higher recall than Exomiser in the singleton benchmark subset.
Singleton subset
67 cases
92 variants
Growing with every interpreted case
SeqSMART continues to expand its interpretation coverage through growing case analysis volume, large-scale precomputed variant knowledge, and adoption by early diagnostic and research users
1,280+
4.6M+
12B+
1,280+
4+
Trusted by diagnostic and research partners, connected through leading innovation networks
Before SeqSMART, complex ACMG classifications could take our team several days of manual review. Now, we can reach an initial interpretation much faster, allowing us to spend more time on the cases that truly require expert attention. The platform doesn’t replace clinical judgment — it strengthens it.
Dr.Ali Ahani
Lead Clinical Geneticist - Mendel lab.
How SeqSMART works
From clinical case to expert ready interpretation
SeqSMART guides diagnostic teams through a structured case workflow, from pedigree creation and phenotype entry to VCF processing, variant prioritization, expert review, and report generation.
Step 1 of 7
Create Case
Start a new clinical case, define the proband, select analysis type, and organize patient and project-level information

Responsible
genomic analysis
SeqSMART is built with security, transparency and compliance at its core, so you can analyze sensitive genomic data with confidence.
Privacy-conscious by design
We follow privacy-first principles to protect sensitive genomic and clinical data.
• Data minimization
• Pseudonymized storage
Secure data infrastructure
Your data is encrypted in transit and at rest, hosted on secure, reliable infrastructure.
• TLS1.2+ in transit
• Encryption (AES-256)
Transparent evidence trail
Every interpretation step is traceable with clear links to sources, criteria and reasoning.
• ACMG criterion mapping
• Linked evidence layers
Expert-review support
SeqSMART augments, not replaces, expert judgment. Final decisions stay in human hands.
• Designed for experts
• Decision support tool
Compliance aware
Committed to global privacy standards and regulatory best practices across all jurisdictions we serve.
• GDPR aware
• CCPA conscious
GDPR Aware
Privacy practices aligned with EU GDPR principles
HIPAA Mindful
Built with healthcare data protection in mind
Secure Hosting
Hosted on enterprise-grade infrastructure
CCPA Conscious
Designed to respect CCPA rights and standards
Join SeqSMART today
Empower your team with integrated evidence, AI-assisted prioritization, and explainable genomics—designed for real-world diagnostic complexity.